Literature DB >> 29449359

Pannexin Channel Inhibition: An Evolving Target to Lower Blood Pressure?

Sabine Huke1.   

Abstract

Entities:  

Keywords:  Editorials; aldosterone; eplerenone; spironolactone

Mesh：

Substances：

Year:  2018        PMID： 29449359      PMCID： PMC5821142          DOI： 10.1161/CIRCRESAHA.118.312566

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  14 in total

1.  Pannexin-1 channels do not regulate α1-adrenoceptor-mediated vasoconstriction in resistance arteries.

Authors:  James A Angus; Ashenafi H Betrie; Christine E Wright
Journal:  Eur J Pharmacol       Date:  2015-01-28       Impact factor: 4.432

2.  Pannexin 1 in erythrocytes: function without a gap.

Authors:  Silviu Locovei; Li Bao; Gerhard Dahl
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 3.  Spironolactone: disposition, metabolism, pharmacodynamics, and bioavailability.

Authors:  A Karim
Journal:  Drug Metab Rev       Date:  1978       Impact factor: 4.518

Review 4.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

5.  Comparison of plasma levels of canrenone and metabolites after base hydrolysis in young and elderly subjects following single and multiple doses of spironolactone.

Authors:  P C Ho; D W Bourne; E J Triggs; B A Smithurst
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Pannexin1 regulates α1-adrenergic receptor- mediated vasoconstriction.

Authors:  Marie Billaud; Alexander W Lohman; Adam C Straub; Robin Looft-Wilson; Scott R Johnstone; Christina A Araj; Angela K Best; Faraaz B Chekeni; Kodi S Ravichandran; Silvia Penuela; Dale W Laird; Brant E Isakson
Journal:  Circ Res       Date:  2011-05-05       Impact factor: 17.367

7.  The membrane protein Pannexin1 forms two open-channel conformations depending on the mode of activation.

Authors:  Junjie Wang; Cinzia Ambrosi; Feng Qiu; David G Jackson; Gina Sosinsky; Gerhard Dahl
Journal:  Sci Signal       Date:  2014-07-22       Impact factor: 8.192

8.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

9.  Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors.

Authors:  Amy McCurley; Paulo W Pires; Shawn B Bender; Mark Aronovitz; Michelle J Zhao; Daniel Metzger; Pierre Chambon; Michael A Hill; Anne M Dorrance; Michael E Mendelsohn; Iris Z Jaffe
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

10.  Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Authors:  Bryan Williams; Thomas M MacDonald; Steve Morant; David J Webb; Peter Sever; Gordon McInnes; Ian Ford; J Kennedy Cruickshank; Mark J Caulfield; Jackie Salsbury; Isla Mackenzie; Sandosh Padmanabhan; Morris J Brown
Journal:  Lancet       Date:  2015-09-20       Impact factor: 79.321
View more
  1 in total

1.  Endothelial pannexin-1 channels modulate macrophage and smooth muscle cell activation in abdominal aortic aneurysm formation.

Authors:  Amanda C Filiberto; Michael D Spinosa; Craig T Elder; Gang Su; Victoria Leroy; Zachary Ladd; Guanyi Lu; J Hunter Mehaffey; Morgan D Salmon; Robert B Hawkins; Kodi S Ravichandran; Brant E Isakson; Gilbert R Upchurch; Ashish K Sharma
Journal:  Nat Commun       Date:  2022-03-21       Impact factor: 17.694
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.